Navigation Links
Neurology Group Lists Procedures That May Be Unneeded
Date:3/8/2013

FRIDAY, March 8 (HealthDay News) -- Five tests, procedures and treatments that neurologists and their patients should question are outlined in a list released by the American Academy of Neurology (AAN) as part of the Choosing Wisely campaign.

"With one in six people affected by a brain disease, such as headache, multiple sclerosis and stroke, our goal is to have patients discuss our Choosing Wisely recommendations regarding medical procedures, therapies, and tests with their neurologists," AAN president Dr. Bruce Sigsbee said in an academy news release.

The American Board of Internal Medicine Foundation-led Choosing Wisely campaign involves about 35 medical specialty groups and is intended to encourage patients and doctors to discuss appropriate care while avoiding unnecessary tests and treatments. The AAN is one of 17 medical societies that recently released advice lists.

Here are the AAN's five neurology-related recommendations:

  • Do not perform electroencephalography (EEG) for headaches. Recurrent headache, which is the most common pain problem, affects up to 20 percent of people. EEG increases costs but has no advantage over clinical evaluation in diagnosing headache and it does not improve outcomes.
  • Do not perform imaging of the carotid arteries in the neck for simple fainting in the absence of other neurologic symptoms. Fainting affects up to 40 percent of people during their lifetime. Carotid artery disease does not cause fainting; rather, it causes focused neurologic problems such as weakness on one side of the body. Therefore, carotid imaging will not identify the cause of the fainting, but it does increase costs.
  • When treating migraine, opioid or butalbital drugs should only be used as a last resort. More effective, migraine-specific treatments are available, and frequent use of these drugs can worsen headaches. Opioid (narcotic) use should be reserved for patients with medical conditions that prevent the use of migraine-specific treatments or for patients for whom these treatments don't work.
  • Do not prescribe interferon-beta or glatiramer acetate to patients with disability from progressive, non-relapsing forms of multiple sclerosis. These medications, often prescribed for MS, do not prevent the development of permanent disability in progressive forms of the disease. However, they do have frequent side effects that may negatively affect quality of life, and increase costs as well.
  • Do not recommend carotid endarterectomy for people who have narrowing of the carotid arteries in the neck but have no symptoms, unless the patient's risk of complication is less than 3 percent. Carotid endarterectomy is a type of surgery meant to reduce the risk of stroke.

The recommendations were published online recently in the journal Neurology.

More information

Here's where you can learn more about the Choosing Wisely campaign.

-- Robert Preidt

SOURCE: American Academy of Neurology, news release, Feb. 21, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Wolters Kluwer Health and the American Academy of Neurology renew partnership
2. Loyola Med student wins prize for excellence in neurology
3. Thomas Eye Group Continues Growth in Metro Atlanta Area With Two Clinic Expansions
4. Lupus Support Group Meeting in Fort Wayne on March 28th
5. Lupus Support Group in Traverse City on March 20th
6. Artisan Business Group brings EB-5 Boot Camp to New York City April 10, 2013
7. Ob-Gyn Group Lists Procedures That May Not Be Needed
8. USHEALTH Advisors Teams with Kristen Zebert to Bring USHEALTH Group Products to Oklahoma
9. Stroud launches Watershed Restoration Group to ensure water quality
10. Pediatrics Group Issues New Ear Infection Guidelines
11. Cunningham Financial Group Encourages Residents of Louisiana to Celebrate American Heart Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the Mission ... lost souls in the Philippines. “The Journey: From the Mountains to the Mission Field” ... the Bible. She has taught all ages and currently teaches a class of ladies ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... introduction of an innovative new design of the shoulder pad. The shoulder pad ... comfort while controlling your pain while using cold therapy. By utilizing ice and water ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
Breaking Medicine Technology: